Publishing research using ab33171? Please let us know so that we can cite the reference in this datasheet.
ab33171 has been referenced in 2 publications.
Megiorni F et al.Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.J Hematol Oncol 10:161 (2017).
Patel Y et al.Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.Thromb Haemost 79:177-85 (1998).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up